Biden Administration Says JnJ Vaccine Will Be Rolled Out ASAP

wagnerap

On Wednesday, the Biden administration COVID-19 team stated that Johnson & Johnson's vaccine could be out next week.

On Wednesday, the Biden administration COVID-19 team stated that Johnson & Johnson's vaccine could be out next week, according to CNBC.

The US currently has 4 million doses of the COVID-19 vaccine. “The governors are carefully planning their efforts and are getting ready for the possible new vaccine,” Jeff Zients, a leader on the response team said. “If authorized, we’re ready to roll out this vaccine without delay.”

“If the EUA is granted, we will waste no time getting this life-saving vaccine into the arms of Americans,” he added.

Since the FDA granted J&J's COVID vaccine emergency authorization approval earlier this morning, it will be interesting to see if the Biden administration can get 3 to 4 million doses of the vaccine out next week. Supposedly states will be given 2 million doses.

The remaining vaccines will be distributed to retail pharmacies and community health centers. J&J has plans to deliver 20 million doses by the end of March, but the Biden administration is working “to accelerate the pace and time frame by which they deliver the full 100 million doses” by the end of June.

The approval of the vaccine does not quell as much angst as many hoped. Johnson & Johnson does not have a very large supply of vaccines at the moment. “I’m a little disappointed that the number of doses that we’re going to get early on from J&J is relatively small, but as we get further into the spring there will be more and more,” White House Chief medical advisor Dr. Anthony Fauci said.

The Biden administration has been working to increase the number of vaccines sent to states each week. When Biden took office in January, states were receiving 8.6 million doses per week. Now, they are receiving 14.5 million doses per week.

However, in recent days inoculations were slowed amid a massive snowstorm that swept over the midwest and Texas, creating supply chain issues. This is the third vaccine the US FDA has approved.

View the Full Story Here.

Comments

U.S. & Global News

FEATURED
COMMUNITY